News-Detail

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D) – but which genes and proteins are actually involved in the disease mechanisms? An international team led by Helmholtz Munich has now used globally collected…

Cardiovascular diseases are the leading cause of death worldwide, and lowering blood lipids is a central strategy to reduce risk. Bempedoic acid, a recently approved cholesterol-lowering drug, has now been shown by researchers at Helmholtz Munich to…

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Healthy gut bacteria concept with natural probiotics for immune support.

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

Big Data Make Hidden Genetic Drivers of Type 2 Diabetes Visible

Cholesterol-Lowering Drug Found to Target Key Metabolic Switch

Inventarisierungssoftware Starfish

Wartungsvertrag Software

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses